COVID-19与心血管疾病
COVID-19 and Cardiovascular Disease
摘要: 冠状病毒(CoVs)是单链正股RNA病毒，具有快速突变和重组的能力。冠状病毒已知会导致人类和动物的呼吸道或肠道感染。急性呼吸道感染，包括流感、呼吸道病毒和细菌性肺炎，是公认的心血管疾病(CVD)的诱因，而潜在的CVD通常与合并症有关，这可能会增加传染病的发病率和严重程度。导致2019年冠状病毒(COVID-19)已迅速发展成大流行，据报告，大部分受影响的患者患有潜在的心血管疾病。在本综述中，我们简要回顾了冠状病毒的基本知识、对心脏损害的发病机制、临床表现及其相关的心血管并发症。我们对COVID-19的了解仍在迅速发展，以进一步深入了解冠状病毒对心血管系统的影响。了解COVID-19对心血管系统的影响对于为心脏病患者提供全面的医疗服务非常关键。
Abstract: Coronavirus (CoVs) is a single-stranded positive stranded RNA virus with the ability of rapid mutation and recombination. Coronaviruses are known to cause respiratory or intestinal infections in humans and animals. Acute respiratory infections, including influenza, respiratory viruses and bacterial pneumonia, are recognized as cardiovascular diseases (CVD). While underlying CVD are often associated with cardiovascular complication which may increase the incidence and severity of infectious diseases. The virus that caused the coronavirus (COVID-19) in 2019 has rapidly evolved into a pandemic, with most of the affected patients reported to have suffered from potential cardiovascular diseases. In this review, we briefly review the basic knowledge of coronaviruses, their pathogenesis of cardiac damage, clinical manifestations and related cardiovascular complications. Our understanding of COVID-19 is still evolving rapidly to further our understanding of the effects of coronavirus on the cardiovascular system. Understanding the effects of COVID-19 on the cardiovascular system is critical to providing comprehensive health care to patients with heart disease.
文章引用：周文丽, 王营忠, 周钰璞, 马金梅. COVID-19与心血管疾病[J]. 临床医学进展, 2021, 11(10): 4560-4565. https://doi.org/10.12677/ACM.2021.1110670

参考文献

[1] Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L. and Zhang, W. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. [Google Scholar] [CrossRef] [PubMed]
[2] Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B. and Song, J. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382, 727-733. [Google Scholar] [CrossRef] 
[3] Lu, R., Zhao, X., Li, J., Niu, P., Yang, B. and Wu, H. (2020) Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. Lancet (London, England), 395, 565-574. [Google Scholar] [CrossRef] 
[4] Shereen, M.A., Khan, S., Kazmi, A., Bashir, N. and Siddique, R. (2020) COVID-19 Infection: Origin, Transmission, and Characteristics of Human Coronaviruses. Journal of Advanced Research, 24, 91-98. [Google Scholar] [CrossRef] [PubMed]
[5] Song, W., Gui, M., Wang, X. and Xiang, Y. (2018) Cryo-EM Structure of the SARS Coronavirus Spike Glycoprotein in Complex with Its Host Cell Receptor ACE2. PLOS Pathogens, 14, 1-19. [Google Scholar] [CrossRef] [PubMed]
[6] Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.-L. and Abiona, O. (2020) Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science, 367, 1260-1263. [Google Scholar] [CrossRef] [PubMed]
[7] Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L. and Zhang, C. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422. [Google Scholar] [CrossRef] 
[8] Inciardi, R.M., Lupi, L., Zaccone, G., Italia, L., Raffo, M. and Tomasoni, D. (2020) Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5, 819-824. [Google Scholar] [CrossRef] [PubMed]
[9] Jose, R.J. and Manuel, A. (2020) COVID-19 Cytokine Storm: The Interplay between Inflammation and Coagulation. The Lancet Respiratory Medicine, 8, e46-e47. [Google Scholar] [CrossRef] 
[10] Lazzerini, P.E., Laghi-Pasini, F., Boutjdir, M. and Capecchi, P.L. (2019) Cardioimmunology of Arrhythmias: The Role of Autoimmune and Inflammatory Cardiac Channelopathies. Nature Reviews Immunology, 19, 63-64. [Google Scholar] [CrossRef] [PubMed]
[11] Hu, H., Ma, F., Wei, X. and Fang, Y. (2020) Coronavirus Fulminant Myocarditis Saved with Glucocorticoid and Human Immunoglobulin. European Heart Journal, 42, 206. [Google Scholar] [CrossRef] [PubMed]
[12] Driggin, E., Madhavan, M.V., Bikdeli, B., Chuich, T., Laracy, J. and Bondi-Zoccai, G. (2020) Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems during the Coronavirus Disease 2019 (COVID-19) Pandemic. Journal of the American College of Cardiology, 75, 2352-2371. [Google Scholar] [CrossRef] [PubMed]
[13] Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J. and Hu, Y. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. [Google Scholar] [CrossRef] 
[14] Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L. and He, T. (2020) Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5, 811-818. [Google Scholar] [CrossRef] [PubMed]
[15] Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y. and Liu, Z. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet (London, England), 395, 1054-1062. [Google Scholar] [CrossRef] 
[16] Tersalvi, G., Vicenzi, M., Calabretta, D., Biasco, L., Pedrazzini, G. and Winterton, D. (2020) Elevated Troponin in Patients with Coronavirus Disease 2019: Possible Mechanisms. Journal of Cardiac Failure, 26, 470-475. [Google Scholar] [CrossRef] [PubMed]
[17] Bojkova, D., Wagner, J.U.G., Shumliakivska, M., Aslan, G.S., Saleem, U. and Hansen, A. (2020) SARS-CoV-2 Infects and Induces Cytotoxic Effects in Human Cardiomyocytes. [Google Scholar] [CrossRef] 
[18] Januzz, J.L. (2020) Troponin and BNP Use in COVID-19. American College of Cardiology, Washington DC, 202.
[19] Chapman, A.R., Bularga, A. and Mills, N.L. (2020) High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight against COVID-19. Circulation, 141, 1733-1735. [Google Scholar] [CrossRef] 
[20] Mahajan, K., Chand Negi, P., Ganju, N. and Asotra, S. (2020) Cardiac Biomarker-Based Risk Stratification Algorithm in Patients with Severe COVID-19. Diabetes & Metabolic Syndrome, 14, 929-931. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, X.-Y., Zhang, F., Zhang, C., Zheng, L.-R. and Yang, J. (2020) The Biomarkers for Acute Myocardial Infarction and Heart Failure. BioMed Research International, 2020, Article ID: 2018035. [Google Scholar] [CrossRef] [PubMed]
[22] Chen, T., Wu, D. and Chen, H. (2020) Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study. BMJ, 368, m1295. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, D., Hu, B. and Hu, C. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069. [Google Scholar] [CrossRef] [PubMed]
[24] Liu, K., Fang, Y.Y. and Deng, Y. (2020) Clinical Characteristics of Novel Coronavirus Cases in Tertiary Hospitals in Hubei Province. Chinese Medical Journal, 133, 1025-1031.
[25] Liu, Y., Yang, Y. and Zhang, C. (2020) Clinical and Biochemical Indexes from 2019-nCoV Infected Patients Linked to Viral Loads and Lung Injury. Science China Life Sciences, 63, 364-374. [Google Scholar] [CrossRef] [PubMed]
[26] Ruan, Q., Yang, K., Wang, W., Jiang, L. and Song, J. (2020) Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China. Intensive Care Medicine, 46, 846-848. [Google Scholar] [CrossRef] [PubMed]
[27] Wu, Z. and McGoogan, J.M. (2020) Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA, 323, 1239-1242. [Google Scholar] [CrossRef] [PubMed]
[28] Welt, F.G.P., Shah, P.B., Aronow, H.D., et al. (2020) Catheterization Laboratory Considerations during the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. Journal of the American College of Cardiology, 75, 2372-2375.
[29] Alhogbani, T. (2016) Acute Myocarditis Associated with Novel Middle East Respiratory Syndrome Coronavirus. Annals of Saudi Medicine, 36, 78-80. [Google Scholar] [CrossRef] [PubMed]
[30] Chen, C., Zhou, Y. and Wang, D.W. (2020) SARS-CoV-2: A Potential Novel Etiology of Fulminant Myocarditis. Herz, 45, 230-232. [Google Scholar] [CrossRef] [PubMed]
[31] Shi, S., Qin, M., Shen, B., et al. (2020) Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Cardiology, 5, 802-810.
[32] Corrales-Medina, V.F., Alvarez, K.N. and Weissfeld, L.A. (2015) Association between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease. JAMA, 313, 264-274. [Google Scholar] [CrossRef] [PubMed]
[33] Kwong, J.C., Schwartz, K.L. and Campitelli, M.A. (2018) Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. The New England Journal of Medicine, 378, 345-353. [Google Scholar] [CrossRef] 
[34] Buzon, J., Roignot, O. and Lemoine, S. (2015) Takotsubo Cardiomyopathy Triggered by Influenza A Virus. Internal Medicine, 54, 2017-2019. [Google Scholar] [CrossRef] [PubMed]
[35] Murthy, S., Gomersall, C.D. and Fowler, R.A. (2020) Care for Critically Ill Patients with COVID-19. JAMA, 323, 1499-1500. [Google Scholar] [CrossRef] [PubMed]
[36] Xie, Y., Wang, X., Yang, P. and Zhang, S. (2020) COVID-19 Complicated by Acute Pulmonary Embolism. Radiology: Cardiothoracic Imaging, 2, e200067. [Google Scholar] [CrossRef] [PubMed]
[37] Danzi, G.B., Loffi, M., Galeazzi, G. and Gherbesi, E. (2020) Acute Pulmonary Embolism and COVID-19 Pneumonia: A Random Association? European Heart Journal, 41, 1858. [Google Scholar] [CrossRef] [PubMed]
[38] Chen, J., Wang, X., Zhang, S., et al. (2020) Findings of Acute Pulmonary Embolism in COVID-19 Patients. The Lancet Infectious Disease.
https://ssrn.com/abstract=3548771
[39] Tang, N., Li, D., Wang, X. and Sun, Z. (2020) Abnormal Coagulation Parameters Are Associated with Poor Prognosis in Patients with Novel Coronavirus Pneumonia. Journal of Thrombosis and Haemostasis, 18, 844-847. [Google Scholar] [CrossRef] [PubMed]
[40] Tang, N., Bai, H. and Chen, X. (2020) Anticoagulant Treatment Is Associated with Decreased Mortality in Severe Coronavirus Disease 2019 Patients with Coagulopathy. Journal of Thrombosis and Haemostasis, 18, 1094-1099. [Google Scholar] [CrossRef] [PubMed]

为你推荐